Head-to-head comparisons of medication uses, side effects, warnings, and more.
Sotyktu (deucravacitinib)
Skyrizi (risankizumab)
Sotyktu (deucravacitinib)
Skyrizi (risankizumab)
Summary of Sotyktu vs. Skyrizi
Summary for Tyrosine kinase 2 inhibitor
Prescription only
Sotyktu (deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor that's used to treat moderate-to-severe plaque psoriasis in adults. It's a tablet that's taken by mouth once per day. Side effects include a higher risk of infections, such as upper respiratory infections and herpes simplex infections. Sotyktu (deucravacitinib) is a brand-name medication and available by prescription only.